Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells.
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002460:Cell Line; D051379:Mice; D009374:Neoplasms, Experimental / Q000201:enzymology; D010703:Phorbol Esters / Q000494:pharmacology*; D010704:Phorbols / Q000494:pharmacology*; D010743:Phospholipids / Q000494:pharmacology*; D011494:Protein Kinases / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013945:Thymoma / Q000201:enzymology*; D013953:Thymus Neoplasms / Q000201:enzymology*
D010703:Phorbol Esters; D010704:Phorbols; D010743:Phospholipids; D011494:Protein Kinases; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium